for subscribers

Investing 2021: Will companies affected by Covid be the best to put your cash into?

Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
According to US investment bank Morgan Stanley, American drug maker Pfizer and German biotech company BioNTech could bring in nearly $13 billion (R19.4 trillion) next year, which the companies will share.
According to US investment bank Morgan Stanley, American drug maker Pfizer and German biotech company BioNTech could bring in nearly $13 billion (R19.4 trillion) next year, which the companies will share.

BUSINESS

If you cast your mind back to what analysts and investment gurus predicted would happen this year, there’s bound to be none who would have guessed the chaos the world would face. Companies and entire sectors have been affected by the Covid-19 coronavirus pandemic and many investors have lost money in their unit trust savings and pensions.

But when share prices dive, there are usually some opportunities to make money, as you can buy at the bottom end of the market and possibly benefit from the upswing. But are there still opportunities to be found next year?

There’s more to this story
Subscribe to News24 and get access to our exclusive journalism and features today.
Subscribe
Already a subscriber? Sign in

E-Editions

Check out the City Press e-edition here.
Read now
Voting Booth
According to a Centre for Social Change and University of Johannesburg survey, 67% of adults would definitely or probably take a Covid-19 vaccine if it became available. Would you/ will you take the vaccine?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, definitely
57% - 59 votes
I definitely would not
24% - 25 votes
I am unsure
18% - 19 votes
Vote